Iovance Biotherapeutics, Inc.
$3.69B- Market cap
- $3.98B
- Debt
- +$1.00M
- Cash
- −$296.98M
Capital structure 100% equity / 0% debt · EV / Revenue 13.99x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
IOVA · current priceP/S 15.11x
$8.79Latest market snapshot
Implied fair value · at FIS's multiple
$1.1886.6% below market
0.58 IOVA revenue / share×2.02x FIS P/S=$1.18
Market $8.79Implied $1.18
FIS · current priceP/S 2.02x
$41.89Latest market snapshot
Implied fair value · at IOVA's multiple
$312.84646.8% above market
20.70 FIS revenue / share×15.11x IOVA P/S=$312.84
Market $41.89Implied $312.84